OneMedNet (US:ONMD) Globenewswire·2025-06-25 12:05Core Insights - OneMedNet Corporation is experiencing strong momentum in 2025, with significant achievements in expanding market presence and enhancing its AI-powered Real-World Data platform [1][2] - The company has onboarded five major data marketplaces and surpassed 121 million clinical exams in its network, indicating robust growth and demand for de-identified data [1][4] Company Highlights - AI-Powered Platform: OneMedNet's federated iRWD™ platform utilizes cost-effective AI tools for data search, de-identification, and curation across various industries, including healthcare, finance, telecom, and retail [4] - Expanded Market Reach: Partnerships with five leading data marketplaces, including Amazon Data Exchange and HealthVerity, enhance the company's position in the healthcare data ecosystem [4] - Network Growth: The company has established partnerships with over 1,400 healthcare provider sites, leading to an organic growth of approximately 5% annually in its medical imaging-rich RWD repository [4] - Amplified Brand Presence: Increased participation in industry events has resulted in over 130 qualified leads, a threefold increase from previous years, reflecting rising market interest [4] - Diverse Customer Base: Leading life sciences organizations license OneMedNet's regulatory-grade datasets for clinical trials and AI model development, showcasing strong market validation [4] - Regulatory Compliance: The datasets meet stringent FDA and international standards, facilitating real-world evidence for regulatory submissions and research [4] Industry Opportunity - The demand for Real-World Data (RWD) is increasing as traditional clinical trial models are being disrupted, with regulators encouraging the use of RWE in the approval process [5] - According to McKinsey, generative AI and RWD could unlock between $60 billion to $110 billion in annual value across the pharmaceutical and medical-device sectors, with healthcare data projected to grow at a 36% CAGR through 2030 [6] Business Model - OneMedNet has introduced a subscription-based Data License Agreement (DLA) structure to drive Annual Recurring Revenue (ARR), allowing near real-time data updates and enhancing scalability [7] Strategic Focus - The company's strategy is anchored on three pillars: Platform, Partners, and People, leveraging its AI capabilities, growing network, and experienced leadership to execute its vision [8]